NCT05485766 2025-03-20Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast CancerOkayama UniversityPhase 2 Recruiting23 enrolled
NCT06616571 2024-09-27Compare the Efficacy and Safety of QL0605 Injections at Different TimepointsQilu Pharmaceutical Co., Ltd.Phase 4 Recruiting336 enrolled